 |
(S)-3-((3-(1-((6-((3,4-dimethoxyphenyl)pryazin-2-yl)amino)ethyl)phenyl)carbamoyl)-5-methylpridin-1-ium |
|---|---|
| Trade Name | |
| Orphan Indication | Pulmonary Arterial Hypertension |
| USA Market Approval | USA |
| USA Designation Date | 2014-11-17 00:00:00 |
| Sponsor | Pulmokine, Inc.;7 University Place, B127B;Rensselaer, New York, 12144 |
